- AU$74.15m
- AU$68.09m
- AU$109.09m
- 95
- 72
- 66
- 89
Annual income statement for Scidev, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 18.1 | 42.5 | 55.6 | 89.7 | 109 |
| Cost of Revenue | |||||
| Gross Profit | 3.3 | 10.2 | 17.4 | 24.2 | 34 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 20.9 | 43.3 | 56.4 | 89.1 | 104 |
| Operating Profit | -2.82 | -0.759 | -0.819 | 0.594 | 4.77 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -2.28 | 0.806 | -1.44 | -0.222 | 4.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.875 | 3.45 | -0.616 | -0.339 | 2.17 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.875 | 3.45 | -0.616 | -0.339 | 2.17 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.875 | 3.45 | -0.616 | -0.339 | 2.17 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.007 | 0.022 | -0.002 | -0.002 | 0.011 |